EMulate Therapeutics, Inc. — Form C (Regulation Crowdfunding)
EMulate Therapeutics, Inc. of Bellevue, WA filed a Form C (Regulation Crowdfunding) with the SEC on 2025-10-08. Target raise $50K, up to $1.2M. Offered through Wefunder Portal LLC.
Offering
- Filed: 2025-10-08
- Form: C
- Accession: 0001254348-25-000003
- Target amount: $50K
- Maximum amount: $1.2M
- Security type: Common Stock
- Securities offered: 5,932
- Price: $10.5400
- Deadline: 2026-04-30
- Funding portal / intermediary: Wefunder Portal LLC
- Intermediary file number: 007-00033
- Intermediary CRD: 283503
Issuer
- CIK: 0001254348
- Website: https://emulatetx.com
- Legal status: Corporation
- Organized in: WA
- Incorporated: 2002-02-07
- Address: 2620 Bellevue Way NE, Bellevue, WA, 98004
- Employees: 3
Financials (as filed)
- Total assets (most recent): $1.2M
- Cash (most recent): $54K
- Revenue (prior): $64K
- Net income (most recent): $-19.1M
- Net income (prior): $-22.9M
- Short-term debt: $31.0M
- Long-term debt: $5.7M
People (8)
| Name | Role | Location |
|---|
| Andrew Daniels | board member Emulate | Providence, RI |
| BENNETT M BUTTERS | Director | SEATTLE, WA |
| Steven Pope | Secretary | Bellevue, WA |
| John Kingma | Director | Bellevue, WA |
| Chris E. Rivera | CEO | Bellevue, WA |
| Kyle J. Kingma | Chief Financial Officer | Bellevue, WA |
| Donna Morgan Murray | Director | Bellevue, WA |
| Charles Mcnerney | Director | Bellevue, WA |
More